Global Aspects of Antimicrobial Resistance among Key Bacterial Pathogens. Results from the 1997-1999 SENTRY Antimicrobial ProgramJONES, Ronald N.Clinical infectious diseases. 2001, Vol 32, issn 1058-4838, 89 p., SUP2Serial Issue

Method preferences and test accuracy of antimicrobial susceptibility testing : Updates from the College of American Pathologists Microbiology Surveys Program (2000)JONES, Ronald N.Archives of pathology & laboratory medicine (1976). 2001, Vol 125, Num 10, pp 1285-1289, issn 0363-0153Article

Microbiology of newer fluoroquinolones: focus on respiratory pathogensJONES, Ronald N.Diagnostic microbiology and infectious disease. 2002, Vol 44, Num 3, pp 213-220, issn 0732-8893, 8 p.Article

Determining the value of antimicrobial surveillance programsJONES, Ronald N; MASTERTON, Robert.Diagnostic microbiology and infectious disease. 2001, Vol 41, Num 4, pp 171-175, issn 0732-8893Conference Paper

Clinical prevalence, Antimicrobial susceptibility, and geographic Resistance patterns of enterococci : Results from the SENTRY Antimicrobial Surveillance Program, 1997-1999LOW, Donald E; KELLER, Nathan; BARTH, Alfonso et al.Clinical infectious diseases. 2001, Vol 32, pp S133-S145, issn 1058-4838, SUP2Article

Antimicrobial activity of daptomycin in comparison to glycopeptides and other antimicrobials when tested against numerous species of coagulase-negative StaphylococcusSADER, Helio S; JONES, Ronald N.Diagnostic microbiology and infectious disease. 2012, Vol 73, Num 2, pp 212-214, issn 0732-8893, 3 p.Article

Multicenter evaluation of the in vitro activity of dalbavancin tested against staphylococci and streptococci in 5 European countries: results from the DECIDE Surveillance Program (2007)BIEDENBACH, Douglas J; JONES, Ronald N.Diagnostic microbiology and infectious disease. 2009, Vol 64, Num 2, pp 177-184, issn 0732-8893, 8 p.Article

Implications of TeqCES: Efficacy and safety of gatifloxacin in community-acquired pneumonia : Symposium on the topic of gatifloxacin (TeqCES trial)MANDELL, Lionel A; JONES, Ronald N.Diagnostic microbiology and infectious disease. 2002, Vol 44, Num 1, pp 127-128, issn 0732-8893, 2 p.Article

Validation of cefditoren MIC quality control ranges by a multi-laboratory study (2001)JONES, Ronald N; BIEDENBACH, Douglas J.Diagnostic microbiology and infectious disease. 2001, Vol 40, Num 1-2, pp 71-73, issn 0732-8893Article

Resistance patterns among nosocomial pathogens : Trends over the past few yearsJONES, Ronald N.Chest. 2001, Vol 119, Num 2, pp 397S-404S, issn 0012-3692, SUPArticle

Treatment of Methicillin-Susceptible Staphylococcus aureus Osteoarticular and Prosthetic Joint Infections: Using the Oxacillin Minimum Inhibitory Concentration to Guide Appropriate Ceftriaxone UseNGUYEN, Hien M; JONES, Ronald N.Clinical infectious diseases. 2013, Vol 57, Num 1, pp 161-162, issn 1058-4838, 2 p.Article

Update of cefditoren activity tested against community-acquired pathogens associated with infections of the respiratory tract and skin and skin structures, including recent pharmacodynamic considerationsBIEDENBACH, Douglas J; JONES, Ronald N.Diagnostic microbiology and infectious disease. 2009, Vol 64, Num 2, pp 202-212, issn 0732-8893, 11 p.Article

Summary trends for the Meropenem Yearly Susceptibility Test Information Collection Program: a 10-year experience in the United States (1999-2008)RHOMBERG, Paul R; JONES, Ronald N.Diagnostic microbiology and infectious disease. 2009, Vol 65, Num 4, pp 414-426, issn 0732-8893, 13 p.Article

Antimicrobial activity of tigecycline (GAR-936) tested against 3498 recent isolates of Staphylococcus aureus recovered from nosocomial and community-acquired infectionsFRITSCHE, Thomas R; JONES, Ronald N.International journal of antimicrobial agents. 2004, Vol 24, Num 6, pp 567-571, issn 0924-8579, 5 p.Article

Comparative spectrum and activity of NVP-PDF386 (VRC4887), a new peptide deformylase inhibitorJONES, Ronald N; RHOMBERG, Paul R.Journal of antimicrobial chemotherapy (Print). 2003, Vol 51, Num 1, pp 157-161, issn 0305-7453, 5 p.Article

Antimicrobial activity of broad-spectrum agents tested against Gram-negative bacilli resistant to ceftazidime: report from the SENTRY Antimicrobial Surveillance Program (North America, 2001)JONES, Ronald N; VARNAM, David J.Diagnostic microbiology and infectious disease. 2002, Vol 44, Num 4, pp 379-382, issn 0732-8893, 4 p.Article

Challenges in Assessing Microbial Susceptibility and Predicting Clinical Response to Newer-Generation FluoroquinolonesSEGRETI, John; JONES, Ronald N; BERTINO, Joseph S et al.Journal of ocular pharmacology and therapeutics. 2012, Vol 28, Num 1, pp 3-11, issn 1080-7683, 9 p.Article

CEM-101 Activity against Gram-Positive OrganismsWOOSLEY, Leah N; CASTANHEIRA, Mariana; JONES, Ronald N et al.Antimicrobial agents and chemotherapy. 2010, Vol 54, Num 5, pp 2182-2187, issn 0066-4804, 6 p.Article

Microbiological features of vancomycin in the 21st century : Minimum inhibitory concentration creep, bacteriddal/static activity, and applied breakpoints to predict clinical outcomes or detect resistant strainsJONES, Ronald N.Clinical infectious diseases. 2006, Vol 42, issn 1058-4838, S13-S24, SUP1Article

Comprehensive in vitro evaluation of cefepime combined with aztreonam or ampicillin/sulbactam against multi-drug resistant Pseudomonas aeruginosa and Acinetobacter sppSADER, Helio S; JONES, Ronald N.International journal of antimicrobial agents. 2005, Vol 25, Num 5, pp 380-384, issn 0924-8579, 5 p.Article

Evaluation of alternative disk diffusion methods for detecting mecA-mediated oxacillin resistance in an international collection of staphylococci: Validation report from the SENTRY Antimicrobial Surveillance ProgramPOTTUMARTHY, Sudha; FRITSCHE, Thomas R; JONES, Ronald N et al.Diagnostic microbiology and infectious disease. 2005, Vol 51, Num 1, pp 57-62, issn 0732-8893, 6 p.Article

Disk diffusion quality control guidelines for NVP-PDF 713: a novel peptide deformylase inhibitorANDEREGG, Tamara R; JONES, Ronald N.Diagnostic microbiology and infectious disease. 2004, Vol 48, Num 1, pp 55-57, issn 0732-8893, 3 p.Article

Preliminary susceptibility testing guidelines for AZD2563, a long-acting oxazolidinoneANDEREGG, Tamara R; JONES, Ronald N.International journal of antimicrobial agents. 2004, Vol 23, Num 1, pp 6-10, issn 0924-8579, 5 p.Article

Bactericidal activity of garenoxacin tested by kill-curve methodology against wild type and QRDR mutant strains of Streptococcus pneumoniaeANDEREGG, Tamara R; JONES, Ronald N.Diagnostic microbiology and infectious disease. 2004, Vol 50, Num 3, pp 213-217, issn 0732-8893, 5 p.Article

Linezolid resistance since 2001: SENTRY antimicrobial surveillance programMUTNICK, Alan H; ENNE, Victoria; JONES, Ronald N et al.The Annals of pharmacotherapy. 2003, Vol 37, Num 6, pp 769-774, issn 1060-0280, 6 p.Article